{"id":568,"date":"2016-03-12T08:01:50","date_gmt":"2016-03-12T14:01:50","guid":{"rendered":"http:\/\/www.illinoisinjurylawyerblog.net\/?p=568"},"modified":"2018-04-12T12:41:35","modified_gmt":"2018-04-12T17:41:35","slug":"fda-warns-women-potential-risks-essure","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/fda-warns-women-potential-risks-essure\/","title":{"rendered":"FDA Warns Women of Potential Risks of Essure"},"content":{"rendered":"

The U.S. Food and Drug Administration (FDA) recently announced<\/a> that it would take actions to provide women with information about the risks of using Essure, a form of permanent birth control. This form of birth control involves inserting flexible coils through the cervix and vagina into the fallopian tubes. After about three months, scar tissue forms around the coils and makes a barrier in order to prevent conception.<\/p>\n

The FDA recognized that there are potential complications related to these types of implantable forms of sterilization and that it should\u00a0take actions in order to address these risks. These actions include requiring a clinical study to assess the risks and requiring warnings on the product labels. The FDA stated that the actions recognize that \u201cmore rigorous research is needed to better understand if certain women are at heightened risk of complications.\u201d<\/p>\n

The FDA, an agency within the U.S. Department of Health and Human Services, protects public health by ensuring that food and drugs are safe for people to use. The FDA\u2019s position is that while Essure is safe for most women, some women may be at risk for complications. Those complications may include pain, tears, bleeding, and allergic reactions.<\/p>\n

Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

The U.S. Food and Drug Administration (FDA) recently announced that it would take actions to provide women with information about the risks of using Essure, a form of permanent birth control. This form of birth control involves inserting flexible coils through the cervix and vagina into the fallopian tubes. After about three months, scar tissue […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19,34],"tags":[],"class_list":["post-568","post","type-post","status-publish","format-standard","hentry","category-dangerous-products","category-prescription-drug-injuries"],"yoast_head":"\nFDA Warns Women of Potential Risks of Essure — Illinois Injury and Mass Tort Lawyer Blog — March 12, 2016<\/title>\n<meta name=\"description\" content=\"The U.S. Food and Drug Administration (FDA) recently announced that it would take actions to provide women with information about the risks of using — March 12, 2016\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/fda-warns-women-potential-risks-essure\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"FDA Warns Women of Potential Risks of Essure — Illinois Injury and Mass Tort Lawyer Blog — March 12, 2016\" \/>\n<meta name=\"twitter:description\" content=\"The U.S. Food and Drug Administration (FDA) recently announced that it would take actions to provide women with information about the risks of using — March 12, 2016\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA Warns Women of Potential Risks of Essure — Illinois Injury and Mass Tort Lawyer Blog — March 12, 2016","description":"The U.S. Food and Drug Administration (FDA) recently announced that it would take actions to provide women with information about the risks of using — March 12, 2016","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/fda-warns-women-potential-risks-essure\/","twitter_card":"summary_large_image","twitter_title":"FDA Warns Women of Potential Risks of Essure — Illinois Injury and Mass Tort Lawyer Blog — March 12, 2016","twitter_description":"The U.S. Food and Drug Administration (FDA) recently announced that it would take actions to provide women with information about the risks of using — March 12, 2016","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.molllawgroup.com\/blog\/fda-warns-women-potential-risks-essure\/#article","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-warns-women-potential-risks-essure\/"},"author":{"name":"Moll Law Group","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"headline":"FDA Warns Women of Potential Risks of Essure","datePublished":"2016-03-12T14:01:50+00:00","dateModified":"2018-04-12T17:41:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-warns-women-potential-risks-essure\/"},"wordCount":632,"articleSection":["Dangerous Products","Prescription Drug Injuries"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/fda-warns-women-potential-risks-essure\/","url":"https:\/\/www.molllawgroup.com\/blog\/fda-warns-women-potential-risks-essure\/","name":"FDA Warns Women of Potential Risks of Essure — Illinois Injury and Mass Tort Lawyer Blog — March 12, 2016","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"datePublished":"2016-03-12T14:01:50+00:00","dateModified":"2018-04-12T17:41:35+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"The U.S. Food and Drug Administration (FDA) recently announced that it would take actions to provide women with information about the risks of using — March 12, 2016","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-warns-women-potential-risks-essure\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/fda-warns-women-potential-risks-essure\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/fda-warns-women-potential-risks-essure\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"FDA Warns Women of Potential Risks of Essure"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=568"}],"version-history":[{"count":1,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/568\/revisions"}],"predecessor-version":[{"id":2114,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/568\/revisions\/2114"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=568"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=568"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}